Brote escolar de parotiditis: estimación de la efectividad vacunal. Zaragoza 2011

Compés-Dea, Cecilia; Guimbao-Bescós, Joaquín; Gaspar-Escayola, José Ignacio; Lázaro-Belanche, María Ángeles; Aznar-Brieba , Amaya.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 33(6): 385-390, jun.-jul. 2015. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-142120

Documentos relacionados

  1. Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.
  2. Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old Children.
  3. Cases of aseptic meningitis after vaccination against mumps in Russia (2009-2019).
  4. Effect of change in cell substrate on the critical quality attributes of L-Zagreb Mumps vaccine manufactured using parallel plate bioreactor.
  5. Third Dose of MMR Vaccine for Mumps Control.
  6. [Epidemiological characteristics of mumps among people aged 0-14 in Jiangxi Province, 2015-2022].
  7. An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland.
  8. Mumps-specific IgG, IgG subclasses and neutralization titres to the vaccine and outbreak mumps strains differ in vaccinated healthy controls, breakthrough mumps infection cases and naturally infected individuals.
  9. Changes in vaccination administration in Japan.
  10. Immunogenicity of novel mumps vaccine candidates generated by genetic modification.